Articles

Professor Gerd Auffarth shares patients’ and colleagues’ responses to a new IOL with a monofocal-like dysphotopsia profile

Phase 1 multicentre study data demonstrate early signs of efficacy

The ESCRS Moving Simulator initiative brings surgical training to nations in need

Dr Ribeiro, President of the European Society of Cataract and Refractive Surgeons, previewed the 2024 congress

The non-diffractive, aspheric IOLs are the second generation of BVI’s ISOPURE family

A case report demonstrates independent effect of GLP-1 receptor agonist

Akantior, an anti-amoebic polymer eye drop, is the first and only authorised medical product for the treatment of AK in the world, according to a news release.

The future of the tech-forward surgical suite

A meta-analysis indicates a "significant association" between vitamin D deficiency and increased risk of RVO

Clinical associations, imaging strategies and establishing a differential diagnosis from pseudopapilloedema

The IOL, designed with artificial intelligence, will launch at this year's ESCRS Congress in Barcelona, Spain

European patients navigate new therapies and market change-ups

The drop breaks up degraded protein complexes which cause lens clouding

Specular microscopy showed "long-term alterations" in corneal cells

Smaller surgeries, in greater numbers, await new glaucoma specialists

Determining the medication’s safety and efficacy for paediatric patients

Lupin has successfully completed a clinical study of LUBT010, a ranibizumab biosimilar to Lucentis

The biosimilar is indicated to improve and maintain visual acuity for patients with neovascular age-related macular degeneration

Diabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.

Stabilising keratoconus and improving vision using ELZA-PACE customised CXL

Identifying all genetic culprits may improve diagnostics and prognoses

A postcard from the American Society of Retina Specialists meeting in Stockholm

The ALLY Adaptive Cataract Treatment System will be the first EU ALLY commercial installation

A list of 14 risk factors indicate dementia is not an inevitable consequence of aging

The nonprofit Prevent Blindness recognised the awareness month with a slate of resources

In a press release, Roche noted that up to 60% of patients were able to extend treatment intervals to 3 or 4 months

The EMA issued a designation for the small molecule photoswitch, which targets inherited retinal diseases including retinitis pigmentosa

Femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) received approval for patients in Europe with primary open-angle glaucoma

The positive opinion comes with the recommendation that ciclosporin 0.1% be granted marketing authorisation in the European Union